Streamlining and Optimization of Third-Party Vendor

Medication Alerts at an Academic Medical Center

Katherine Moser, Kendall Shoaf, Anish Choksi, Charlene Hope, Seth Hartman

The University of Chicago Medicine

References

  1.  Berner, Eta S., ed. Clinical Decision Support Systems. New York, NY: Springer, 2007. AM J Health Syst Pharm. 72.17 (2015): 1499-   1505.

  2.  Page N, Baysari MT, Westbrook JI. A systematic review of the effectiveness of interruptive medication prescribing alerts in hospital   CPOE systems to change prescriber behavior and improve patient safety. Int J Med Inform. 2017 Sep;105:22-30. doi:                         10.1016/j.ijmedinf.2017.05.011. Epub 2017.

  3.  Mustafa I Hussain, Tera L Reynolds, Kai Zheng, Medication safety alert fatigue may be reduced via interaction design and clinical   role tailoring: a systematic review, Journal of the American Medical Informatics Association, Volume 26, Issue 10, October 2019,   Pages 1141–1149,

  4.  Saiyed SM, Davis KR, Kaelber DC. Differences, Opportunities, and Strategies in Drug Alert Optimization-Experiences of Two   Different Integrated Health Care Systems. Appl Clin Inform. 2019 Oct;10(5):777-782. doi: 10.1055/s-0039-1697596. Epub 2019.

  5.  John D. McGreevey JD, Mallozzi CP, Perkins RM et al. Reducing Alert Burden in Electronic Health Records: State of the Art   Recommendations from Four Health Systems. Appl Clin Inform 2020; 11(01): 001-012.doi: 10.1055/s-0039-3402715

  6.  Sijs H, Aarts J, PhD, Gelder TV et al. Turning Off Frequently Overridden Drug Alerts: Limited Opportunities for Doing It Safely,   Journal of the American Medical Informatics Association. July 2008, 439–448, https://doi.org/10.1197/jamia.M2311.

  7.  Phansalkar et al.Criteria for assessing high-priority drug-drug interactions for clinical decision support in electronic health records.   BMC Medical Informatics and Decision Making 2013, 13:65. http://www.biomedcentral.com/1472-6947/13/65

Disclosures

The authors of this presentation have no financial interests with commercial entities that may have a direct or indirect interest in the subject matter of this presentation

Get in Touch

123-456-7890 

  • Facebook
  • Twitter
  • LinkedIn
  • Instagram